share

Quinoxaline, 2-Ethyl-5,6,7,8-Tetrahydro-3-Methyl-, 1,4-Dioxide (9Ci) CAS NO 424810-21-9


Unit Price:

CAS No.:424810-21-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Quinoxaline, 2-Ethyl-5,6,7,8-Tetrahydro-3-Methyl-, 1,4-Dioxide (9Ci) is a specialized heterocyclic compound belonging to the quinoxaline dioxide class, identified by CAS NO 424810-21-9. This chemical is valued for its unique structural features, which make it a versatile intermediate in advanced organic synthesis and pharmaceutical research. It is primarily sought after by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and fine chemical industries for creating novel active ingredients and functional materials.

Application

  • Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel drug candidates, particularly those targeting infectious diseases or central nervous system disorders.
  • Agrochemical Research: Used in the development of new fungicides, herbicides, or plant growth regulators, leveraging its heterocyclic core for biological activity.
  • Organic Synthesis Reagent: Acts as a precursor or intermediate in complex organic transformations, including cyclization and functionalization reactions.
  • Material Science Research: Investigated for the development of advanced organic electronic materials, such as charge-transport layers or light-emitting components.
  • Chemical Biology Probe: Utilized in academic and industrial research to study enzyme interactions or as a scaffold for designing molecular probes.

Basic Information

Product Name Quinoxaline, 2-Ethyl-5,6,7,8-Tetrahydro-3-Methyl-, 1,4-Dioxide (9Ci)
CAS No. 424810-21-9
Molecular Formula C11H16N2O2
Molecular Weight 208.26 g/mol
Synonyms 2-Ethyl-5,6,7,8-tetrahydro-3-methylquinoxaline 1,4-dioxide; 3-Methyl-2-ethyl-5,6,7,8-tetrahydroquinoxaline-1,4-dioxide; 2-Ethyl-3-methyl-5,6,7,8-tetrahydroquinoxaline 1,4-dioxide; Tetrahydro-3-methyl-2-ethylquinoxaline-1,4-dioxide; Quinoxaline, 2-ethyl-5,6,7,8-tetrahydro-3-methyl-, 1,4-dioxide; 424810-21-9 (CAS); 2-Ethyl-3-methyl-1,4-dioxo-1,2,3,4-tetrahydroquinoxaline (tautomeric form)
EINECS Contact for details

Quality Control

Our Quinoxaline, 2-Ethyl-5,6,7,8-Tetrahydro-3-Methyl-, 1,4-Dioxide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR), to ensure it meets the high standards required for research and development applications. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from heat, sparks, and open flame. Due to its light-sensitive nature, handling and storage should minimize exposure to direct or strong artificial light.

Specification

Item Specification
Appearance Off-white to light yellow crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Conforms to reference standard
Purity (HPLC) ≥ 97.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.